A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce the risk of heart attacks and other serious cardiac events even when ...
Cytokinetics Inc. won US approval for a drug to treat a deadly heart condition, posing a potential threat to sales of a ...
It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...
Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...
Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major ...
News-Medical.Net on MSN
Imaging-enhanced knowledge graphs reveal new targets for heart disease treatment
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
Heart disease medication plays a critical role in managing and preventing cardiovascular conditions. Understanding the various types, their mechanisms, and how they work can help people make informed ...
Please provide your email address to receive an email when new articles are posted on . Recreational drug use was detected among 11% of patients admitted to cardiac ICUs. Cannabis, cocaine and MDMA ...
An analysis of cardiac arrest records in a U.S. registry revealed that people with drug overdose cardiac arrests were more likely to be younger, have fewer health conditions and have higher survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results